# Camp4 Therapeutics Corp: Form 8-K, filed Sep 28, 2026

- Company: [Camp4 Therapeutics Corp](/companies/camp.md) (CIK 1736730)
- Form: 8-K
- Filed: 2026-09-28
- Accepted by EDGAR: Sep 28, 2026, 16:47 ET
- Period: 2026-09-28
- Accession: 0001628280-26-063740
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736730/000162828026063740/camp-20260928.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736730/000162828026063740/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736730/000162828026063740/camp-20260928.htm

Filed Sep 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-063740. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.